HC Wainwright restated their buy rating on shares of CalciMedica (NASDAQ:CALC – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a $20.00 price target on the stock. Separately, Oppenheimer reissued an outperform rating and set a $14.00 price objective on shares of CalciMedica in a report […]
Related Keywords
Freda Middleton , , Capital Management , Calcimedica Inc , Free Report , Medica Stock Down , Director Fred , Portfolio Management , Hudson Bay Capital Management , Get Free Report , Calcimedica Daily , Calcimedica , Nasdaq Calc , Calc , Medical , Reiterated Rating , Hc Wainwright ,
vimarsana.com © 2020. All Rights Reserved.